NUWELLIS, INC.

NUWE ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $8.3M $8.7M $8.9M $8.5M $7.9M $7.4M $5.5M $5.0M
Cost of Revenue $3.1M $3.1M $3.9M $3.8M $3.4M $3.4M $2.7M $3.7M
Gross Profit $5.1M $5.7M $5.0M $4.8M $4.5M $4.1M $2.9M $1.3M
Gross Margin 62.0% 64.9% 56.2% 55.7% 56.7% 54.5% 51.7% 26.6%
Operating Expenses
Research & Development $2.7M $3.2M $5.4M $4.3M $5.0M $3.7M $4.7M $3.1M
SG&A Expense $13.5M $13.5M $17.2M $17.6M $19.0M $17.4M $16.3M $15.3M
Operating Income $-11.1M $-11.0M $-17.6M $-17.2M $-19.5M $-17.0M $-18.1M $-17.0M
Operating Margin -134.3% -125.7% -198.9% -201.0% -246.5% -228.8% -328.5% -340.9%
Interest Expense
Pretax Income $-17.5M $-11.2M $-20.2M $-14.5M $-19.5M $-15.8M $-18.1M $-17.0M
Income Tax Expense $5.0K $5.0K $8.0K $9.0K $9.0K $9.0K $8.0K $6.0K
Net Income $-17.5M $-11.2M $-20.2M $-14.5M $-19.6M $-15.8M $-18.1M $-17.0M
Net Margin -211.9% -127.7% -228.0% -170.0% -246.9% -212.8% -328.7% -340.8%
EPS (Basic) $-25.39 $-16.06 $-16.37 $-3.80 $-4.32 $-0.16 $-4.23 $-0.64
EPS (Diluted) $-25.39 $-16.06 $-16.37 $-3.80 $-4.32 $-0.16 $-4.23 $-0.64
Shares Outstanding (Basic) 690.1K 695.2K 1.2M 3.8M 4.6M 108.8M 10.3M 33.9M
Shares Outstanding (Diluted) 690.1K 695.2K 1.2M 3.8M 4.6M 108.8M 10.3M 33.9M
Dividends Per Share
← Newer Page 1 of 2 Older →